Recent advances in the treatment of Hodgkin's disease.
Most patients who present with Hodgkin's disease today can be cured of their disease. Current treatments strive to maintain a high level of efficacy while reducing side effects that limit the quality and length of survival. Sophisticated molecular techniques continue to aid our understanding of the etiology and pathogenesis of this disease. However, the heterogeneity and paucity of "malignant" cells in Hodgkin's disease continue to limit our ability to articulate a coherent and encompassing model.
Yuen
A R
AR
Division of Oncology, Stanford University School of Medicine, CA 94304, USA.
Horning
S J
SJ
D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans